Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 59

1.

HIV-1 Escape From RNAi Antivirals: Yet Another Houdini Action?

Berkhout B, Das AT.

Mol Ther Nucleic Acids. 2012 Jun 12;1:e26. doi: 10.1038/mtna.2012.22. No abstract available.

2.

Response to "HIV Escape From RNAi Antivirals: Yet Another Houdini Action?".

Shah PS, Schaffer DV.

Mol Ther Nucleic Acids. 2012 Jun 12;1:e28. doi: 10.1038/mtna.2012.23. No abstract available.

3.

Molecular strategies to design an escape-proof antiviral therapy.

Berkhout B, Sanders RW.

Antiviral Res. 2011 Oct;92(1):7-14. doi: 10.1016/j.antiviral.2011.04.002. Epub 2011 Apr 12. Review.

PMID:
21513746
4.

Lentiviral delivery of RNAi effectors against HIV-1.

Liu YP, Berkhout B.

Curr Top Med Chem. 2009;9(12):1130-43. Review.

PMID:
19860713
5.

RNAi as a treatment for HIV-1 infection.

Rossi JJ.

Biotechniques. 2006 Apr;Suppl:25-9. Review.

7.

Toward a durable anti-HIV gene therapy based on RNA interference.

Berkhout B.

Ann N Y Acad Sci. 2009 Sep;1175:3-14. doi: 10.1111/j.1749-6632.2009.04972.x. Review.

PMID:
19796072
8.

RNA interference as a tool for exploring HIV-1 robustness.

Nevot M, Martrus G, Clotet B, Martínez MA.

J Mol Biol. 2011 Oct 14;413(1):84-96. doi: 10.1016/j.jmb.2011.08.035. Epub 2011 Aug 22.

PMID:
21875599
9.

HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome.

Westerhout EM, Ooms M, Vink M, Das AT, Berkhout B.

Nucleic Acids Res. 2005 Feb 1;33(2):796-804. Print 2005.

10.

Toward a durable treatment of HIV-1 infection using RNA interference.

Eekels JJ, Berkhout B.

Prog Mol Biol Transl Sci. 2011;102:141-63. doi: 10.1016/B978-0-12-415795-8.00001-5. Review.

PMID:
21846571
11.

Transfer of antivirals across the human placenta.

Pacifici GM.

Early Hum Dev. 2005 Aug;81(8):647-54. Review.

PMID:
15946808
12.

Stringent testing identifies highly potent and escape-proof anti-HIV short hairpin RNAs.

von Eije KJ, ter Brake O, Berkhout B.

J Gene Med. 2009 Jun;11(6):459-67. doi: 10.1002/jgm.1329.

PMID:
19384894
13.

Betulinic acid derivatives as HIV-1 antivirals.

Aiken C, Chen CH.

Trends Mol Med. 2005 Jan;11(1):31-6. Review.

PMID:
15649820
14.

RNA-interference-based gene therapy approaches to HIV type-1 treatment: tackling the hurdles from bench to bedside.

von Eije KJ, Berkhout B.

Antivir Chem Chemother. 2009;19(6):221-33. Review.

PMID:
19641231
15.

RNAi as an antiviral therapy.

Bagasra O.

Expert Opin Biol Ther. 2005 Nov;5(11):1463-74. Review.

PMID:
16255650
18.

Antivirals other than for HIV therapy.

Harrison CJ.

Adv Pediatr. 2000;47:335-94. Review.

PMID:
10959449
19.

Update on HIV resistance and resistance testing.

Sebastian J, Faruki H.

Med Res Rev. 2004 Jan;24(1):115-25. Review.

PMID:
14595674
20.
Items per page

Supplemental Content

Write to the Help Desk